| Date | Time | Source | Headline | Symbol | Company |
| 08/15/2011 | 4:33AM | Zacks | Allos Therapeutics Evenly Poised - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/09/2011 | 12:38PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/09/2011 | 12:35PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/09/2011 | 6:03AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/05/2011 | 10:30AM | Zacks | Revenues Rise at Allos, Awaits Merger - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/04/2011 | 4:34PM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/04/2011 | 4:33PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/04/2011 | 4:00PM | Business Wire | Allos Therapeutics Reports Second Quarter 2011 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/03/2011 | 5:25PM | Dow Jones News | 2nd UPDATE: AMAG Pharma Gets Offer From Fund Opposing Allos Deal | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/29/2011 | 4:32PM | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/28/2011 | 11:15AM | Zacks | AMAG Trims Loss, Sales Remain Weak - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/28/2011 | 11:15AM | Zacks | AMAG Trims Loss, Sales Remain Weak - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/28/2011 | 8:55AM | Zacks | Celgene Tops, Lifts View - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/28/2011 | 8:55AM | Zacks | Celgene Tops, Lifts View - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/28/2011 | 8:00AM | Business Wire | Allos Therapeutics to Report Second Quarter 2011 Results on August 4, 2011 | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/27/2011 | 12:21PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/26/2011 | 4:09PM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/26/2011 | 6:06AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/22/2011 | 6:02AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/22/2011 | 6:02AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/22/2011 | 6:01AM | Edgar (US Regulatory) | Filing of certain prospectuses and communications in connection with business combination transactions (425) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/21/2011 | 6:39PM | Business Wire | The Law Firm of Weiss & Lurie Announces Investigation of Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/21/2011 | 5:25PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/21/2011 | 4:05PM | Business Wire | Law Offices of Howard G. Smith Announces Investigation of Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/21/2011 | 3:37PM | Business Wire | Bull & Lifshitz, LLP Announces Investigation of Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/21/2011 | 10:01AM | Business Wire | Goldfarb Branham Law Firm LLP Investigates Allos Therapeutics Inc Company | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/21/2011 | 8:00AM | Zacks | AMAG to Merge with Allos - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 9:55PM | Business Wire | MURRAY FRANK LLP Investigates Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 9:40PM | Business Wire | The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 07/20/2011 | 8:21PM | Business Wire | Robbins Umeda LLP Announces an Investigation of Allos Therapeutics, Inc. | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |